Non-ownership Filings
License Agreement with Allogene Therapeutics | Mar. 24, 2020 |
Consolidation of Trading Lines | Feb. 21, 2020 |
AIM Block Admission Return / Total Voting Rights | Feb. 20, 2020 |
MaxCyte to Present at BIO CEO & Investor Conf | Feb. 05, 2020 |
Trading Update | Jan. 20, 2020 |
New Executive Vice President and Trial Update | Dec. 19, 2019 |
Agreement with KSQ Therapeutics | Dec. 04, 2019 |
Ownership Update Filings
Grant Of Options | Jan. 24, 2020 |
Holding(s) in Company | Jan. 22, 2020 |
Holding(s) in Company | Jan. 22, 2020 |
Holding(s) in Company | Jan. 22, 2020 |
Director/PCA transaction initial notification | Dec. 16, 2019 |
Director Dealings | Mar. 19, 2019 |
Director Dealings | Dec. 17, 2018 |